Company intelligence / Profile preview

Quantapore

Menlo Park, California, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Quantapore is developing a novel nanopore-based sequencing technology intended for rapid, affordable, and accurate analysis of nucleic acids and proteins. The product is in the pre-commercial stage with no clinical trial results yet reported. The technology aims to improve on existing sequencing methods through its high throughput, optical nanopore system allowing single molecule detection.

Modalities: DeviceAnalytical platform
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Quantapore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quantapore.

Explore the full profile